Your browser doesn't support javascript.
loading
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study.
Ku, Jennifer H; Sy, Lina S; Qian, Lei; Ackerson, Bradley K; Luo, Yi; Tubert, Julia E; Lee, Gina S; Florea, Ana; Bruxvoort, Katia J; Xie, Fagen; Qiu, Sijia; Chavers, Scott; Talarico, Carla A; Tseng, Hung Fu.
Affiliation
  • Ku JH; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA. Electronic address: Jen.H.Ku@kp.org.
  • Sy LS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Qian L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Tubert JE; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Lee GS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Florea A; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Bruxvoort KJ; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Xie F; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Qiu S; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Chavers S; Moderna Inc., Cambridge, MA 02139, USA.
  • Talarico CA; Moderna Inc., Cambridge, MA 02139, USA.
  • Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA 91101, USA.
Vaccine ; 41(29): 4212-4219, 2023 06 29.
Article in En | MEDLINE | ID: mdl-37301708
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: COVID-19 / 2019-nCoV Vaccine mRNA-1273 Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: COVID-19 / 2019-nCoV Vaccine mRNA-1273 Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2023 Document type: Article